Taisho Pharmaceutical Co., Ltd.
🇯🇵Japan
Long-Term Study of TS-142 in Patients with Insomnia
Phase 3
Completed
- Conditions
- Patients with Insomnia
- Interventions
- Drug: TS-142 10 mgDrug: TS-142 5 mg
- First Posted Date
- 2022-07-18
- Last Posted Date
- 2025-02-28
- Lead Sponsor
- Taisho Pharmaceutical Co., Ltd.
- Target Recruit Count
- 401
- Registration Number
- NCT05461352
- Locations
- 🇯🇵
Taisho Pharmaceutical Co., Ltd selected site, Tokyo, Japan
Phase III Study of TS-142 in Patients with Insomnia
Phase 3
Completed
- Conditions
- Patients with Insomnia
- Interventions
- Drug: Placebo to TS-142Drug: TS-142 5 mgDrug: TS-142 10 mg
- First Posted Date
- 2022-07-12
- Last Posted Date
- 2025-02-28
- Lead Sponsor
- Taisho Pharmaceutical Co., Ltd.
- Target Recruit Count
- 1155
- Registration Number
- NCT05453136
- Locations
- 🇯🇵
Taisho Pharmaceutical Co., Ltd selected site, Tokyo, Japan
A Phase I Study of TS-172 in Healthy Adult Subjects (Single and Multiple Doses)
- First Posted Date
- 2021-07-28
- Last Posted Date
- 2025-02-28
- Lead Sponsor
- Taisho Pharmaceutical Co., Ltd.
- Target Recruit Count
- 41
- Registration Number
- NCT04979572
- Locations
- 🇯🇵
Taisho Pharmaceutical Co., Ltd selected site, Toshima-ku, Japan
A QT/QTc Evaluation Study of TS-142 in Healthy Adult Subjects
- First Posted Date
- 2021-05-05
- Last Posted Date
- 2025-02-28
- Lead Sponsor
- Taisho Pharmaceutical Co., Ltd.
- Target Recruit Count
- 59
- Registration Number
- NCT04873323
- Locations
- 🇯🇵
Taisho Pharmaceutical Co., Ltd selected site, Toshima-ku, Japan
Mass Balance Study of TS-142 in Healthy Adult Subjects.
Phase 1
Completed
- Conditions
- Healthy Male Subjects
- Interventions
- Drug: [14C] TS-142
- First Posted Date
- 2021-03-24
- Last Posted Date
- 2025-02-28
- Lead Sponsor
- Taisho Pharmaceutical Co., Ltd.
- Target Recruit Count
- 6
- Registration Number
- NCT04814771
- Locations
- 🇯🇵
Taisho Pharmaceutical Co., Ltd selected site, Tokyo, Japan
A Clinical Pharmacology Study of TS-142 in Patients with Obstructive Sleep Apnea Hypopnea.
Phase 1
Completed
- Conditions
- Patients with Mild Obstructive Sleep Apnea Hypopnea
- Interventions
- Drug: Dose-matched Placebo to TS-142
- First Posted Date
- 2021-02-09
- Last Posted Date
- 2025-02-28
- Lead Sponsor
- Taisho Pharmaceutical Co., Ltd.
- Target Recruit Count
- 46
- Registration Number
- NCT04746105
- Locations
- 🇯🇵
Taisho Pharmaceutical Co., Ltd selected site, Tokyo, Japan
A Study to Evaluate Next Day Effects of TS-142 on Driving Performance in Healthy Subjects
- First Posted Date
- 2021-01-06
- Last Posted Date
- 2025-02-28
- Lead Sponsor
- Taisho Pharmaceutical Co., Ltd.
- Target Recruit Count
- 61
- Registration Number
- NCT04696952
- Locations
- 🇯🇵
Taisho Pharmaceutical Co., Ltd selected site, Tokyo, Japan
Clinical Study on Histamine H3 Receptor Occupancy of TS-091 by PET Examination in Healthy Adult Subjects
- First Posted Date
- 2020-11-17
- Last Posted Date
- 2025-02-28
- Lead Sponsor
- Taisho Pharmaceutical Co., Ltd.
- Target Recruit Count
- 12
- Registration Number
- NCT04631276
- Locations
- 🇯🇵
Taisho Pharmaceutical Co., Ltd selected site, Tokyo, Japan
Early Phase 2 Clinical Study of TS-142 in Patients with Insomnia Disorder
Phase 2
Completed
- Conditions
- Insomnia Disorder
- Interventions
- Drug: Dose-matched Placebo to TS-142
- First Posted Date
- 2020-10-05
- Last Posted Date
- 2025-02-28
- Lead Sponsor
- Taisho Pharmaceutical Co., Ltd.
- Target Recruit Count
- 24
- Registration Number
- NCT04573725
- Locations
- 🇯🇵
Taisho Pharmaceutical Co., Ltd selected site, Tokyo, Japan
Drug-drug Interaction Study with TS-142 in Healthy Adult Subjects (concomitant Administration of Itraconazole)
- First Posted Date
- 2020-09-21
- Last Posted Date
- 2025-02-28
- Lead Sponsor
- Taisho Pharmaceutical Co., Ltd.
- Target Recruit Count
- 10
- Registration Number
- NCT04557163
- Locations
- 🇯🇵
Taisho Pharmaceutical Co., Ltd selected site, Tokyo, Japan
© Copyright 2025. All Rights Reserved by MedPath